24.02 USD
+0.38 (+1.61%)
24.02 USD
0 (0%)
Overall PRVA gets a fundamental rating of 4 out of 10. We evaluated PRVA against 102 industry peers in the Health Care Providers & Services industry. PRVA has a great financial health rating, but its profitability evaluates not so good. PRVA is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
PRVA had positive earnings in the past year.
In the past year PRVA had a positive cash flow from operations.
In multiple years PRVA reported negative net income over the last 5 years.
In the past 5 years PRVA always reported a positive cash flow from operatings.
1.2 Ratios
With a Return On Assets value of 1.34%, PRVA perfoms like the industry average, outperforming 52.94% of the companies in the same industry.
PRVA's Return On Equity of 2.56% is in line compared to the rest of the industry. PRVA outperforms 56.86% of its industry peers.
PRVA has a Return On Invested Capital (2.45%) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.34% | ||
| ROE | 2.56% | ||
| ROIC | 2.45% |
ROA(3y)0.83%
ROA(5y)-3.09%
ROE(3y)1.55%
ROE(5y)-3.63%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
PRVA has a Profit Margin of 0.89%. This is comparable to the rest of the industry: PRVA outperforms 53.92% of its industry peers.
In the last couple of years the Profit Margin of PRVA has declined.
PRVA has a Operating Margin (1.38%) which is in line with its industry peers.
PRVA's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 10.17%, PRVA is not doing good in the industry: 75.49% of the companies in the same industry are doing better.
PRVA's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.38% | ||
| PM (TTM) | 0.89% | ||
| GM | 10.17% |
OM growth 3YN/A
OM growth 5Y-13.74%
PM growth 3YN/A
PM growth 5Y-4.5%
GM growth 3Y15.6%
GM growth 5Y3.18%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), PRVA is destroying value.
Compared to 1 year ago, PRVA has more shares outstanding
PRVA has more shares outstanding than it did 5 years ago.
There is no outstanding debt for PRVA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
An Altman-Z score of 4.47 indicates that PRVA is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.47, PRVA is in the better half of the industry, outperforming 79.41% of the companies in the same industry.
PRVA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 4.47 |
ROIC/WACC0.28
WACC8.9%
2.3 Liquidity
PRVA has a Current Ratio of 1.67. This is a normal value and indicates that PRVA is financially healthy and should not expect problems in meeting its short term obligations.
PRVA has a better Current ratio (1.67) than 62.75% of its industry peers.
A Quick Ratio of 1.67 indicates that PRVA should not have too much problems paying its short term obligations.
PRVA has a better Quick ratio (1.67) than 67.65% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.67 | ||
| Quick Ratio | 1.67 |
3. Growth
3.1 Past
PRVA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 30.00%, which is quite impressive.
PRVA shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.43% yearly.
Looking at the last year, PRVA shows a quite strong growth in Revenue. The Revenue has grown by 19.01% in the last year.
Measured over the past years, PRVA shows a quite strong growth in Revenue. The Revenue has been growing by 17.17% on average per year.
EPS 1Y (TTM)30%
EPS 3YN/A
EPS 5Y7.43%
EPS Q2Q%66.67%
Revenue 1Y (TTM)19.01%
Revenue growth 3Y21.58%
Revenue growth 5Y17.17%
Sales Q2Q%27.1%
3.2 Future
Based on estimates for the next years, PRVA will show a very strong growth in Earnings Per Share. The EPS will grow by 69.59% on average per year.
The Revenue is expected to grow by 2.73% on average over the next years.
EPS Next Y22%
EPS Next 2Y70.67%
EPS Next 3Y69.59%
EPS Next 5YN/A
Revenue Next Year20.28%
Revenue Next 2Y14.98%
Revenue Next 3Y13.19%
Revenue Next 5Y2.73%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
PRVA is valuated quite expensively with a Price/Earnings ratio of 184.77.
Compared to the rest of the industry, the Price/Earnings ratio of PRVA is on the same level as its industry peers.
When comparing the Price/Earnings ratio of PRVA to the average of the S&P500 Index (26.39), we can say PRVA is valued expensively.
With a Price/Forward Earnings ratio of 74.96, PRVA can be considered very expensive at the moment.
The rest of the industry has a similar Price/Forward Earnings ratio as PRVA.
PRVA is valuated expensively when we compare the Price/Forward Earnings ratio to 23.84, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 184.77 | ||
| Fwd PE | 74.96 |
4.2 Price Multiples
PRVA's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. PRVA is more expensive than 61.76% of the companies in the same industry.
PRVA's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 26.69 | ||
| EV/EBITDA | 66.15 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as PRVA's earnings are expected to grow with 69.59% in the coming years.
PEG (NY)8.4
PEG (5Y)24.85
EPS Next 2Y70.67%
EPS Next 3Y69.59%
5. Dividend
5.1 Amount
No dividends for PRVA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
24.02
+0.38 (+1.61%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners98.69%
Inst Owner Change2.16%
Ins Owners1.85%
Ins Owner Change0.2%
Market Cap2.95B
Revenue(TTM)2.04B
Net Income(TTM)18.17M
Analysts84.44
Price Target32.18 (33.97%)
Short Float %2.7%
Short Ratio4.07
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-34.97%
Min EPS beat(2)-60.96%
Max EPS beat(2)-8.97%
EPS beat(4)0
Avg EPS beat(4)-37.14%
Min EPS beat(4)-60.96%
Max EPS beat(4)-8.97%
EPS beat(8)0
Avg EPS beat(8)-42.01%
EPS beat(12)3
Avg EPS beat(12)40.52%
EPS beat(16)6
Avg EPS beat(16)56.54%
Revenue beat(2)2
Avg Revenue beat(2)11.82%
Min Revenue beat(2)5.73%
Max Revenue beat(2)17.91%
Revenue beat(4)4
Avg Revenue beat(4)8.08%
Min Revenue beat(4)0.75%
Max Revenue beat(4)17.91%
Revenue beat(8)8
Avg Revenue beat(8)5.39%
Revenue beat(12)10
Avg Revenue beat(12)0.33%
Revenue beat(16)10
Avg Revenue beat(16)-9.08%
PT rev (1m)-0.02%
PT rev (3m)3.18%
EPS NQ rev (1m)-2.78%
EPS NQ rev (3m)-41.97%
EPS NY rev (1m)-20.77%
EPS NY rev (3m)-18.68%
Revenue NQ rev (1m)0.61%
Revenue NQ rev (3m)-0.48%
Revenue NY rev (1m)4.09%
Revenue NY rev (3m)3.76%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 184.77 | ||
| Fwd PE | 74.96 | ||
| P/S | 1.45 | ||
| P/FCF | 26.69 | ||
| P/OCF | 26.69 | ||
| P/B | 4.17 | ||
| P/tB | 8 | ||
| EV/EBITDA | 66.15 |
EPS(TTM)0.13
EY0.54%
EPS(NY)0.32
Fwd EY1.33%
FCF(TTM)0.9
FCFY3.75%
OCF(TTM)0.9
OCFY3.75%
SpS16.61
BVpS5.77
TBVpS3
PEG (NY)8.4
PEG (5Y)24.85
Graham Number4.11
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.34% | ||
| ROE | 2.56% | ||
| ROCE | 3.67% | ||
| ROIC | 2.45% | ||
| ROICexc | 5.77% | ||
| ROICexgc | N/A | ||
| OM | 1.38% | ||
| PM (TTM) | 0.89% | ||
| GM | 10.17% | ||
| FCFM | 5.42% |
ROA(3y)0.83%
ROA(5y)-3.09%
ROE(3y)1.55%
ROE(5y)-3.63%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5Y-10.22%
OM growth 3YN/A
OM growth 5Y-13.74%
PM growth 3YN/A
PM growth 5Y-4.5%
GM growth 3Y15.6%
GM growth 5Y3.18%
F-Score7
Asset Turnover1.51
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 112.37 | ||
| Cash Conversion | 296.89% | ||
| Profit Quality | 609.36% | ||
| Current Ratio | 1.67 | ||
| Quick Ratio | 1.67 | ||
| Altman-Z | 4.47 |
F-Score7
WACC8.9%
ROIC/WACC0.28
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)30%
EPS 3YN/A
EPS 5Y7.43%
EPS Q2Q%66.67%
EPS Next Y22%
EPS Next 2Y70.67%
EPS Next 3Y69.59%
EPS Next 5YN/A
Revenue 1Y (TTM)19.01%
Revenue growth 3Y21.58%
Revenue growth 5Y17.17%
Sales Q2Q%27.1%
Revenue Next Year20.28%
Revenue Next 2Y14.98%
Revenue Next 3Y13.19%
Revenue Next 5Y2.73%
EBIT growth 1Y114.42%
EBIT growth 3YN/A
EBIT growth 5Y1.07%
EBIT Next Year573.2%
EBIT Next 3Y111.25%
EBIT Next 5Y64.24%
FCF growth 1Y142.02%
FCF growth 3Y26.09%
FCF growth 5Y42.42%
OCF growth 1Y141.5%
OCF growth 3Y25.67%
OCF growth 5Y35.01%
PRIVIA HEALTH GROUP INC / PRVA FAQ
What is the fundamental rating for PRVA stock?
ChartMill assigns a fundamental rating of 4 / 10 to PRVA.
What is the valuation status for PRVA stock?
ChartMill assigns a valuation rating of 2 / 10 to PRIVIA HEALTH GROUP INC (PRVA). This can be considered as Overvalued.
Can you provide the profitability details for PRIVIA HEALTH GROUP INC?
PRIVIA HEALTH GROUP INC (PRVA) has a profitability rating of 3 / 10.
What is the valuation of PRIVIA HEALTH GROUP INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for PRIVIA HEALTH GROUP INC (PRVA) is 184.77 and the Price/Book (PB) ratio is 4.17.
What is the earnings growth outlook for PRIVIA HEALTH GROUP INC?
The Earnings per Share (EPS) of PRIVIA HEALTH GROUP INC (PRVA) is expected to grow by 22% in the next year.